As part of a competition law enforcement and anti-corruption program, the firm regularly intervenes to train and update the knowledge of employees of a pharmaceutical company, a subsidiary of a Multinational UK company.
In an extension of an on-line training program, employees are made aware of the risks incurred by their company in the event of non-compliance, and learn how to avoid them: what are the behaviors likely to constitute a cartel, which reaction to have in a situation where the company may be at risk, how to respond to a DGCCRF survey and which rules should be applied regarding benefits in kind or gifts?
